FDA Issues Warning for Diabetes Medication Liraglutide (Victoza)

What are you looking for?

Washington, DC: The FDA has issued a warning regarding Liraglutide (Victoza), a drug used in the treatment of diabetes, and a possible risk for thyroid cancer and pancreatitis.

Liraglutide is approved for use as adjunct therapy to diet and exercise to improve glycemic control in type 2 diabetes.

Studies done in rats show that liraglutide causes thyroid C-cell tumors, when exposed to the drug in clinically similar doses to those administered in humans. However, no association has been proven in humans, although clinical trials show some patients developed papillary thyroid carcinomas. Additionally, liraglutide is associated with a higher rate of pancreatitis than other diabetes medications. Consequently, the FDA recommends patient monitoring after starting liraglutide or raising the dosage, for symptoms including persistent severe abdominal pain

According to media reports, the FDA found that a recent evaluation of some primary care providers showed the providers were unaware of the serious risks associated with liraglutide.

Legal Help

If you or a loved one has suffered illness or damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Please click here for a free evaluation of your case

Last updated on Jun-15-11

LEGAL HELP NOW!

Please complete this form to request a review of your complaint by an attorney.

First name:

Last name:

Email address:

Phone number(s):

State:

Zip Code:

Defendant:

Describe your complaint:

Subscribe to our free newsletter

There is absolutely no cost to you to submit this form. Doing so places you under no obligations and does not establish an attorney-client relationship.

Legal Help Now!

CLICK HERE

Related Lawsuits

Legal Services: